Skip to main content
. 2022 Jun 10;13:918899. doi: 10.3389/fendo.2022.918899

Table 5.

Ovarian function outcome after transplantation.

Size of processed ovarian tissue (No. of OTT Participants) Months from OTT HP mean ± SD, range HP lasting ≥6 months n, (%) HP lasting ≥1 year n, (%) HP lasting ≥ 2 years n, (%) HP ≥ 5 years n, (%) Participants with ongoing ovarian function n, (%) Participants with reported cessation of ovarianfunction n, (%)
Strips
1st (n = 51)
2nd (n = 8)
3.88 ± 0.84, 1.6-7.5 49/51, (96)
7/8, (87.5)
45/51,
(88.2)
7/8, (87.5)
19/51, (37.3)
4/8, (50)
2/51, (4)
1/8, (12.5)
42/51, (84)
6/8, (75)
9q/51, (17.6)
2q/8, (25)
Squares
1st (n = 9)
2nd (n = 2)
3.56 ± 1.03,
1.8-4.6
8/9, (88.9)
1/2, (50)
4/9, (44.4)
1/2, (50)
3/9, (33.3)
0/2, (0)
0/9, (0)
0/2, (0)
5/9, (55.6)
1/2, (50)
4/9, (44.4)
1q/2, (50)
Fragments
1st (n = 3)
3 ± 2,
1-5
3/3, (100) 1/3, (33.3) 0/3, (0) 0/3, (0) 3/3, (100) 0/3, (0)

qParticipant did not have resumption of ovarian activity. HP, hormone production (21, 22, 25, 34, 37, 44, 57, 59, 61, 64, 66, 78, 84, 91, 92, 95, 111, 115, 124).